Media
Anesiva's media center is designed to provide reporters with easy access to news about the company and its products for stories in development. If you don't find what you are looking for or need more information, please contact us.
Click here to download our most recent fact sheet.
|
= Add Release to Briefcase |
All Releases |
|
Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
Aug 28, 2007
|
11.0 KB
|
|
SOUTH SAN FRANCISCO, Calif., Aug 28, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that it has completed enrollment of the Phase 3 clinical study of Zingo(TM) (lidocaine hydrochloride monohydrate) powder intradermal injection system to reduce pain associated with peripheral venous access procedu...
|
|
|
Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
Aug 17, 2007
|
14.9 KB
|
|
SOUTH SAN FRANCISCO, Calif., Aug 17, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that the U.S. Food and Drug Administration (FDA) has approved Zingo(TM) (lidocaine hydrochloride monohydrate) powder intradermal injection system, which provides rapid, topical, local analgesia to reduce the pain ...
|
|
|
Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
Aug 16, 2007
|
9.7 KB
|
|
SOUTH SAN FRANCISCO, Calif., Aug 16, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) will announce an encouraging development in the Zingo(TM) development program before the markets open tomorrow. A conference call and live webcast will be held at 8:30 a.m. Eastern Time tomorrow to discuss the announcement.
I...
|
|
|
Anesiva Announces Second Quarter 2007 Financial Results
Jul 26, 2007
|
16.5 KB
|
|
SOUTH SAN FRANCISCO, Calif., July 26, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) today reported financial results for the second quarter ended June 30, 2007 and provided an update on its clinical development programs for Zingo(TM) and Adlea(TM) (previously 4975).
"We are continuing to work with the FDA i...
|
|
|
Anesiva to Announce Second Quarter 2007 Financial Results and Host Webcast Conference Call on July 26, 2007
Jul 20, 2007
|
10.5 KB
|
|
SOUTH SAN FRANCISCO, July 20, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) will announce financial results for the second quarter 2007 after the markets close on Thursday, July 26, 2007 and will hold a webcast teleconference at 4:30 p.m. EDT that day. Members of Anesiva's management team will discuss financial...
|
|
|